Generation of β cells from human pluripotent stem cells: are we there yet?


In 1998, the landmark paper describing the isolation and culture of human embryonic stem cells (ESCs) was published. Since that time, the main goal of many diabetes researchers has been to derive β cells from ESCs as a renewable cell-based therapy for the treatment of patients with diabetes. In working toward this goal, numerous protocols that attempt to… (More)
DOI: 10.1111/nyas.12369


  • Presentations referencing similar topics